Why did ALSAF.PA stock drop intraday today?

ALSAF.PA stock fell due to higher-than-average selling, weak liquidity (current ratio 0.03) and negative operating cash flow. Traders reacted to balance-sheet risk and below-average fundamentals, causing volume of 9,766 to spike and the price to move to €0.84.

What is Meyka AI’s view and grade for ALSAF.PA?

Meyka AI rates ALSAF.PA **63.86 out of 100 (Grade B)** with a HOLD suggestion. The grade balances product potential against poor cash flow and negative EPS. This is informational and not investment advice.

What price targets and forecast exist for ALSAF.PA stock?

Meyka AI's forecast model projects a monthly target of **€1.06** and a quarterly target of **€1.03**. Versus the current **€0.84**, those imply upside of **+26.19%** and **+22.62%** respectively. Forecasts are model-based and not guarantees.

What are the main risks to consider for ALSAF.PA?

Main risks include continued negative operating cash flow, possible dilution if capital is raised, and fragile liquidity metrics. ALSAF.PA’s EPS and book value are deeply negative, so funding actions or revenue improvement are needed to reduce risk.

EU Stocks

ALSAF.PA stock down 15.92% intraday 03 Feb 2026: watch near-term liquidity risk

ByHuzaifa Zahoor February 3, 2026

ALSAF.PA stock slid 15.92% intraday to €0.84 on 03 Feb 2026, marking the session among top losers on EURONEXT. The move followed heavy selling from an open of €0.91 and volume of 9,766 shares, above the 3-month average of 6,439. Investors are pricing in near-term funding and operational risk after a string of weak metrics, while the Healthcare sector average remains stronger. This intraday fall sharpens focus on liquidity, operating cash flow, and whether short-term technical support holds